Katherine Hilsinger
Obstetrics & Gynecology · Newport News, VANPI 1871584631
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,615 of the $9,719 with a category attached, or 68.1%. CSL Plasma Inc. accounts for 68.1% of it on its own, with 29 other manufacturers making up the rest. 2025 is the largest year on record at $6,615, 6.8 times the $978 reported in 2019. Among obstetrics & gynecology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 120 payments — averaging $80.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Plasma Inc.$7K
- AbbVie$744
- Astellas Pharma US Inc$657
- Novo Nordisk$224
- Daiichi Sankyo Inc.$220
- Medtronic$210
- plus $1K from 24 others
What the payments were for
- Consulting fees$6,61568%
- Food & beverage$2,89330%
- Education$2112%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Plasma Inc. | 5 | $6,615 |
| AbbVie(2 entities) | 28 | $744 |
| Astellas Pharma US Inc | 17 | $657 |
| Novo Nordisk | 3 | $224 |
| Daiichi Sankyo Inc. | 6 | $220 |
| Medtronic(2 entities) | 9 | $210 |
| Therapeuticsmd, Inc. | 5 | $172 |
| Myovant Sciences Inc. | 3 | $150 |
| Amgen | 8 | $127 |
| Merck | 5 | $81 |
| Urovant Sciences Inc | 3 | $51 |
| Mayne Pharma Commercial LLC | 2 | $36 |
| Axonics, Inc. | 3 | $36 |
| Neos Therapeutics, LP | 1 | $36 |
| Bayer | 2 | $33 |
| AMAG Pharmaceuticals, Inc. | 2 | $31 |
| Lupin Inc. | 2 | $30 |
| Pfizer | 2 | $28 |
| Vertical Pharmaceuticals, LLC | 2 | $28 |
| Minerva Surgical, Inc | 2 | $27 |
| Davol Inc. | 1 | $23 |
| Teleflex LLC | 1 | $22 |
| Evofem Biosciences, Inc. | 1 | $22 |
| Tesaro, Inc. | 1 | $20 |
| Indivior Inc. | 1 | $20 |
| Agile Therapeutics, Inc. | 1 | $18 |
| Organon | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Exeltis, USA Inc. | 1 | $14 |
| Covidien LP | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,719 in reported general payments places this provider in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 24 | $1,457 |
| Bupropion XlBupropion Hcl | 11 | $268 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Newport News
- Jeffrey MorrisonNewport News$27K
- Karen FishNewport News$19K
- Laura CordesNewport News$16K
- Norma Jones-IvesNewport News$10K
- Branden DeyerleNewport News$10K
- Jawwad KhanNewport News$8K
- Thomas KimbleNorfolk$286K
- Jack AyoubLeesburg$279K
- Kurian ThottStafford$216K
- Nina SmithHarrisonburg$199K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.